A Case of Prostatic Signet-Ring Cell-like Carcinoma with Pagetoid Spread and Intraductal Carcinoma and Long-Term Survival: PD-L1 and Mismatch Repair System Proteins (MMR) Immunohistochemical Evaluation with Systematic Literature Review

Author:

Koufopoulos Nektarios1ORCID,Ieronimaki Argyro-Ioanna1,Zacharatou Andriani1ORCID,Gouloumis Alina Roxana1,Leventakou Danai1ORCID,Boutas Ioannis2ORCID,Dimas Dionysios T.3,Kontogeorgi Adamantia4,Sitara Kyparissia5,Khaldi Lubna6ORCID,Zanelli Magda7ORCID,Palicelli Andrea7ORCID

Affiliation:

1. Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece

2. Breast Unit, Rea Maternity Hospital, P. Faliro, 17564 Athens, Greece

3. Breast Unit, Athens Medical Center, Psychiko Clinic, 11525 Athens, Greece

4. Third Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece

5. Department of Internal Medicine, “Elpis” General Hospital of Athens, 11522 Athens, Greece

6. Pathology Department “Saint Savvas” Anti-Cancer Hospital, 10447 Athens, Greece

7. Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy

Abstract

Prostatic adenocarcinoma (PA) is the second most common malignancy in men globally. Signet-ring cell-like adenocarcinoma (SRCC) is a very rare PA subtype, with around 200 cases reported in the English literature. Histologically, the tumor cells show a vacuole compressing the nucleus to the periphery. Pagetoid spread in acini and ducts is usually related to metastases from urothelial or colorectal carcinomas, less commonly associated with intraductal carcinoma (IC); histologically, the tumor cells grow between the acinar secretory and basal cell layers. To our knowledge, we report the first prostatic SRCC (Gleason score 10, stage pT3b) associated with IC and pagetoid spread to prostatic acini and seminal vesicles. To our systematic literature review (PRISMA guidelines), it is the first tested case for both PD-L1 (<1% of positive tumor cells, clone 22C3) and mismatch repair system proteins (MMR) (MLH1+/MSH2+/PMS2+/MSH6+). We found no SRCC previously tested for MMR, while only four previous cases showed high expression of another PD-L1 clone (28-8). Finally, we discussed the differential diagnoses of prostatic SRCC.

Funder

Italian Ministry of Health

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference67 articles.

1. Epidemiology and prevention of prostate cancer;Gandaglia;Eur. Urol. Oncol.,2021

2. Immunohistochemical analysis of PD-L1 and tumor-infiltrating immune cells expression in the tumor microenvironment of primary signet ring cell carcinoma of the prostate;Teng;Asian J. Androl.,2022

3. Signet ring adenocarcinoma of the prostate;Giltman;J. Urol.,1981

4. Prostatic carcinoma with signet ring cells: A clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature;Torbenson;Mod. Pathol.,1998

5. Primary prostatic signet ring cell carcinoma in elderly with obstructive uropathy: A case report;Sidhu;Afr. J. Urol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3